PTI-808/PTI-801

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePTI-808/PTI-801
Drug Alias NamePTI-808+PTI-801PTI-801+PTI-808
ClassificationSmall molecules
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator stimulants
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes PTI-801Dirocaftor
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesProteostasis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesProteostasis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A